Evidence map›Paper›PMID 37008254›Full record

ArticleAdvances in radiation oncology

Comparison of Gonadal Toxicity of Single-Fraction Ultra-High Dose Rate and Conventional Radiation in Mice.

Maria C Cuitiño, Jessica L Fleming, Sagarika Jain, Ashley Cetnar, Ahmet S Ayan, Jeffrey Woollard, Heather Manring, Wei Meng, Joseph P McElroy, Dukagjin M Blakaj and 2 more

Open access · goldAbstract read
In one paragraph

Article in Advances in radiation oncology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 13 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Microenvironmental remodeling in FLASH radiotherapy.Frontiers in cell and developmental biology · 2026
    Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Maria C CuitiñoDepartment of Radiation Oncology, Arthur G. James Hospital, Comprehensive Cancer Center, Columbus, Ohio.
Jessica L FlemingDepartment of Radiation Oncology, Arthur G. James Hospital, Comprehensive Cancer Center, Columbus, Ohio.
Sagarika JainDepartment of Radiation Oncology, Arthur G. James Hospital, Comprehensive Cancer Center, Columbus, Ohio.
Ashley CetnarDepartment of Radiation Oncology, Arthur G. James Hospital, Comprehensive Cancer Center, Columbus, Ohio.
Ahmet S AyanDepartment of Radiation Oncology, Arthur G. James Hospital, Comprehensive Cancer Center, Columbus, Ohio.
Jeffrey WoollardDepartment of Radiation Oncology, Arthur G. James Hospital, Comprehensive Cancer Center, Columbus, Ohio.
Heather ManringDepartment of Radiation Oncology, Arthur G. James Hospital, Comprehensive Cancer Center, Columbus, Ohio.
Wei MengDepartment of Radiation Oncology, Arthur G. James Hospital, Comprehensive Cancer Center, Columbus, Ohio.
Joseph P McElroyDepartment of Biomedical Informatics, Center for Biostatistics, Ohio State University, Columbus, Ohio.
Dukagjin M BlakajDepartment of Radiation Oncology, Arthur G. James Hospital, Comprehensive Cancer Center, Columbus, Ohio.
Nilendu GuptaDepartment of Radiation Oncology, Arthur G. James Hospital, Comprehensive Cancer Center, Columbus, Ohio.
Arnab ChakravartiDepartment of Radiation Oncology, Arthur G. James Hospital, Comprehensive Cancer Center, Columbus, Ohio.
The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute · USThe Ohio State University · US

Funding

OSU as Network Lead Academic Participating Site for the NCI NCTNU10CA180850 · NCI · OHIO STATE UNIVERSITY · PI BLUM, KRISTIE A, CHAKRAVARTI, ARNAB · 2014 to 2018
$6.8M
Signal Transduction Pathways in GlioblastomaR01CA108633 · NCI · OHIO STATE UNIVERSITY · PI CHAKRAVARTI, ARNAB · 2005 to 2009
$2.3M
TOWARDS A REFINED MOLECULAR RECURSIVE PARTITIONING ANALYSIS MODEL FOR GLIOBLASTOMRC2CA148190 · NCI · AMERICAN COLLEGE OF RADIOLOGY · PI ALDAPE, KENNETH D, CHAKRAVARTI, ARNAB · 2009 to 2010
$2.1M
Therapeutic Exploitation of Mutant BRAF for AstrocytomaR01CA169368 · NCI · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI HOUGHTON, PETER J · 2013 to 2017
$1.6M
NCI NIH HHS R01 CA108633NCI NIH HHS R01 CA169368NCI NIH HHS RC2 CA148190NCI NIH HHS U10 CA180850
6 · The paper itself

Abstract

Purpose: Increasing evidence suggests that ultra-high-dose-rate (UHDR) radiation could result in similar tumor control as conventional (CONV) radiation therapy (RT) while reducing toxicity to surrounding healthy tissues. Considering that radiation toxicity to gonadal tissues can cause hormone disturbances and infertility in young patients with cancer, the purpose of this study was to assess the possible role of UHDR-RT in reducing toxicity to healthy gonads in mice compared with CONV-RT. Methods and Materials: Radiation was delivered to the abdomen or pelvis of female (8 or 16 Gy) and male (5 Gy) C57BL/6J mice, respectively, at conventional (∼0.4 Gy/s) or ultrahigh (>100 Gy/s) dose rates using an IntraOp Mobetron linear accelerator. Organ weights along with histopathology and immunostaining of irradiated gonads were used to compare toxicity between radiation modalities. Results: CONV-RT and UHDR-RT induced a similar decrease in uterine weights at both studied doses (∼50% of controls), which indicated similarly reduced ovarian follicular activity. Histologically, ovaries of CONV- and UHDR-irradiated mice exhibited a comparable lack of follicles. Weights of CONV- and UHDR-irradiated testes were reduced to ∼30% of controls, and the percentage of degenerate seminiferous tubules was also similar between radiation modalities (∼80% above controls). Pairwise comparisons of all quantitative data indicated statistical significance between irradiated (CONV or UHDR) and control groups (from Conclusions: The data presented here suggest that the short-term effects of UHDR-RT on the mouse gonads are comparable to those of CONV-RT.

Identifiers

PMID37008254
PMCPMC10050676
OpenAlexW4321602084

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.